nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—Eplerenone—coronary artery disease	0.35	1	CrCtD
Drospirenone—NR3C2—coronary artery disease	0.176	0.854	CbGaD
Drospirenone—NR3C2—Eplerenone—coronary artery disease	0.0995	0.57	CbGbCtD
Drospirenone—Spironolactone—Eplerenone—coronary artery disease	0.0341	0.185	CrCrCtD
Drospirenone—BCHE—Perindopril—coronary artery disease	0.0324	0.186	CbGbCtD
Drospirenone—PTGS2—coronary artery disease	0.0301	0.146	CbGaD
Drospirenone—Medroxyprogesterone Acetate—Eplerenone—coronary artery disease	0.0278	0.15	CrCrCtD
Drospirenone—BCHE—Ramipril—coronary artery disease	0.0268	0.154	CbGbCtD
Drospirenone—Cortisone acetate—Eplerenone—coronary artery disease	0.0243	0.132	CrCrCtD
Drospirenone—Testosterone Propionate—Eplerenone—coronary artery disease	0.0211	0.114	CrCrCtD
Drospirenone—Progesterone—Eplerenone—coronary artery disease	0.0211	0.114	CrCrCtD
Drospirenone—Methyltestosterone—Eplerenone—coronary artery disease	0.0206	0.111	CrCrCtD
Drospirenone—Testosterone—Eplerenone—coronary artery disease	0.0183	0.0993	CrCrCtD
Drospirenone—Hydrocortisone—Eplerenone—coronary artery disease	0.0172	0.0933	CrCrCtD
Drospirenone—PTGS2—Acetylsalicylic acid—coronary artery disease	0.0156	0.0897	CbGbCtD
Drospirenone—Thromboembolic event—Fenofibrate—coronary artery disease	0.00133	0.0318	CcSEcCtD
Drospirenone—Venous thromboembolism—Fenofibrate—coronary artery disease	0.00122	0.0291	CcSEcCtD
Drospirenone—Infarction—Trandolapril—coronary artery disease	0.00104	0.0247	CcSEcCtD
Drospirenone—Infarction—Enalapril—coronary artery disease	0.00103	0.0246	CcSEcCtD
Drospirenone—Infarction—Ramipril—coronary artery disease	0.000775	0.0185	CcSEcCtD
Drospirenone—Loss of libido—Lovastatin—coronary artery disease	0.00076	0.0181	CcSEcCtD
Drospirenone—PGR—artery—coronary artery disease	0.000729	0.104	CbGeAlD
Drospirenone—Embolism venous—Fenofibrate—coronary artery disease	0.000712	0.017	CcSEcCtD
Drospirenone—Loss of libido—Simvastatin—coronary artery disease	0.000711	0.0169	CcSEcCtD
Drospirenone—Infarction—Lisinopril—coronary artery disease	0.000703	0.0167	CcSEcCtD
Drospirenone—Loss of libido—Valsartan—coronary artery disease	0.000672	0.016	CcSEcCtD
Drospirenone—Loss of libido—Pravastatin—coronary artery disease	0.000643	0.0153	CcSEcCtD
Drospirenone—Loss of libido—Captopril—coronary artery disease	0.000596	0.0142	CcSEcCtD
Drospirenone—Embolism—Fenofibrate—coronary artery disease	0.00056	0.0133	CcSEcCtD
Drospirenone—NR3C2—cardiac ventricle—coronary artery disease	0.00044	0.0627	CbGeAlD
Drospirenone—Myocardial infarction—Tirofiban—coronary artery disease	0.000427	0.0102	CcSEcCtD
Drospirenone—NR3C2—myocardium—coronary artery disease	0.000414	0.059	CbGeAlD
Drospirenone—Affect lability—Penbutolol—coronary artery disease	0.000394	0.0094	CcSEcCtD
Drospirenone—Haemoglobin—Tirofiban—coronary artery disease	0.000393	0.00937	CcSEcCtD
Drospirenone—Haemorrhage—Tirofiban—coronary artery disease	0.000391	0.00932	CcSEcCtD
Drospirenone—Breast pain—Eplerenone—coronary artery disease	0.000386	0.0092	CcSEcCtD
Drospirenone—PGR—myocardium—coronary artery disease	0.000385	0.0548	CbGeAlD
Drospirenone—Mood swings—Penbutolol—coronary artery disease	0.00038	0.00905	CcSEcCtD
Drospirenone—Thrombosis—Furosemide—coronary artery disease	0.000367	0.00875	CcSEcCtD
Drospirenone—PTGS2—artery—coronary artery disease	0.000364	0.0519	CbGeAlD
Drospirenone—Breast pain—Niacin—coronary artery disease	0.000346	0.00823	CcSEcCtD
Drospirenone—AR—cardiac ventricle—coronary artery disease	0.000326	0.0464	CbGeAlD
Drospirenone—Eplerenone—CYP11B2—coronary artery disease	0.000322	0.216	CrCbGaD
Drospirenone—Breast disorder—Gemfibrozil—coronary artery disease	0.000309	0.00736	CcSEcCtD
Drospirenone—Depression—Penbutolol—coronary artery disease	0.000308	0.00734	CcSEcCtD
Drospirenone—PTGS2—endothelium—coronary artery disease	0.000308	0.0438	CbGeAlD
Drospirenone—AR—myocardium—coronary artery disease	0.000306	0.0437	CbGeAlD
Drospirenone—Breast disorder—Ticagrelor—coronary artery disease	0.000302	0.00719	CcSEcCtD
Drospirenone—NR3C2—heart—coronary artery disease	0.000289	0.0412	CbGeAlD
Drospirenone—NR3C2—cardiovascular system—coronary artery disease	0.000273	0.0388	CbGeAlD
Drospirenone—Breast disorder—Rosuvastatin—coronary artery disease	0.000272	0.00647	CcSEcCtD
Drospirenone—PGR—heart—coronary artery disease	0.000268	0.0383	CbGeAlD
Drospirenone—BCHE—cardiac ventricle—coronary artery disease	0.000265	0.0378	CbGeAlD
Drospirenone—Depression—Gemfibrozil—coronary artery disease	0.000263	0.00626	CcSEcCtD
Drospirenone—Migraine—Fenofibrate—coronary artery disease	0.000257	0.00612	CcSEcCtD
Drospirenone—PGR—cardiovascular system—coronary artery disease	0.000253	0.0361	CbGeAlD
Drospirenone—NR3C2—cardiac atrium—coronary artery disease	0.000247	0.0352	CbGeAlD
Drospirenone—Haemoglobin—Ticagrelor—coronary artery disease	0.000232	0.00553	CcSEcCtD
Drospirenone—Haemorrhage—Ticagrelor—coronary artery disease	0.000231	0.00551	CcSEcCtD
Drospirenone—Depression—Rosuvastatin—coronary artery disease	0.000231	0.00551	CcSEcCtD
Drospirenone—Eplerenone—NR3C2—coronary artery disease	0.000228	0.153	CrCbGaD
Drospirenone—Breast disorder—Ezetimibe—coronary artery disease	0.000226	0.00538	CcSEcCtD
Drospirenone—Breast pain—Lisinopril—coronary artery disease	0.000224	0.00533	CcSEcCtD
Drospirenone—Spironolactone—CYP11B2—coronary artery disease	0.00022	0.147	CrCbGaD
Drospirenone—NR3C2—blood—coronary artery disease	0.000216	0.0307	CbGeAlD
Drospirenone—Migraine—Niacin—coronary artery disease	0.000215	0.00513	CcSEcCtD
Drospirenone—AR—heart—coronary artery disease	0.000214	0.0305	CbGeAlD
Drospirenone—Cerebrovascular accident—Trandolapril—coronary artery disease	0.000214	0.00509	CcSEcCtD
Drospirenone—Cerebrovascular accident—Enalapril—coronary artery disease	0.000213	0.00507	CcSEcCtD
Drospirenone—Affect lability—Pravastatin—coronary artery disease	0.000212	0.00505	CcSEcCtD
Drospirenone—Angiopathy—Ticagrelor—coronary artery disease	0.00021	0.005	CcSEcCtD
Drospirenone—Mental disorder—Gemfibrozil—coronary artery disease	0.000207	0.00494	CcSEcCtD
Drospirenone—Migraine—Trandolapril—coronary artery disease	0.000206	0.00491	CcSEcCtD
Drospirenone—Mood swings—Pravastatin—coronary artery disease	0.000204	0.00486	CcSEcCtD
Drospirenone—Cerebrovascular accident—Captopril—coronary artery disease	0.000204	0.00486	CcSEcCtD
Drospirenone—Haemoglobin—Acetylsalicylic acid—coronary artery disease	0.000203	0.00484	CcSEcCtD
Drospirenone—Mental disorder—Ticagrelor—coronary artery disease	0.000202	0.00482	CcSEcCtD
Drospirenone—Migraine—Telmisartan—coronary artery disease	0.000202	0.00482	CcSEcCtD
Drospirenone—Haemorrhage—Acetylsalicylic acid—coronary artery disease	0.000202	0.00482	CcSEcCtD
Drospirenone—AR—cardiovascular system—coronary artery disease	0.000202	0.0288	CbGeAlD
Drospirenone—PGR—blood—coronary artery disease	0.0002	0.0285	CbGeAlD
Drospirenone—Acute coronary syndrome—Fenofibrate—coronary artery disease	0.000198	0.00472	CcSEcCtD
Drospirenone—Cerebrovascular accident—Perindopril—coronary artery disease	0.000198	0.00472	CcSEcCtD
Drospirenone—Myocardial infarction—Fenofibrate—coronary artery disease	0.000197	0.0047	CcSEcCtD
Drospirenone—Depression—Clopidogrel—coronary artery disease	0.000197	0.0047	CcSEcCtD
Drospirenone—Migraine—Perindopril—coronary artery disease	0.000191	0.00455	CcSEcCtD
Drospirenone—Breast disorder—Trandolapril—coronary artery disease	0.000189	0.00451	CcSEcCtD
Drospirenone—Depression—Eplerenone—coronary artery disease	0.000188	0.00448	CcSEcCtD
Drospirenone—Acute coronary syndrome—Eplerenone—coronary artery disease	0.000186	0.00443	CcSEcCtD
Drospirenone—Breast disorder—Telmisartan—coronary artery disease	0.000186	0.00443	CcSEcCtD
Drospirenone—Myocardial infarction—Eplerenone—coronary artery disease	0.000185	0.0044	CcSEcCtD
Drospirenone—Mood swings—Perindopril—coronary artery disease	0.000184	0.00438	CcSEcCtD
Drospirenone—Depression—Simvastatin—coronary artery disease	0.000183	0.00436	CcSEcCtD
Drospirenone—AR—cardiac atrium—coronary artery disease	0.000183	0.0261	CbGeAlD
Drospirenone—Mental disorder—Rosuvastatin—coronary artery disease	0.000182	0.00434	CcSEcCtD
Drospirenone—Migraine—Losartan—coronary artery disease	0.000179	0.00427	CcSEcCtD
Drospirenone—Haemoglobin—Clopidogrel—coronary artery disease	0.000178	0.00425	CcSEcCtD
Drospirenone—Haemorrhage—Clopidogrel—coronary artery disease	0.000177	0.00423	CcSEcCtD
Drospirenone—Breast disorder—Perindopril—coronary artery disease	0.000175	0.00418	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Gemfibrozil—coronary artery disease	0.000174	0.00415	CcSEcCtD
Drospirenone—BCHE—heart—coronary artery disease	0.000174	0.0248	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Ticagrelor—coronary artery disease	0.00017	0.00405	CcSEcCtD
Drospirenone—Erythema multiforme—Clopidogrel—coronary artery disease	0.000168	0.004	CcSEcCtD
Drospirenone—Erythema multiforme—Lovastatin—coronary artery disease	0.000167	0.00397	CcSEcCtD
Drospirenone—Depression—Pravastatin—coronary artery disease	0.000166	0.00395	CcSEcCtD
Drospirenone—Nausea—Tirofiban—coronary artery disease	0.000165	0.00393	CcSEcCtD
Drospirenone—Nervous system disorder—Gemfibrozil—coronary artery disease	0.000165	0.00393	CcSEcCtD
Drospirenone—Breast disorder—Losartan—coronary artery disease	0.000164	0.00392	CcSEcCtD
Drospirenone—BCHE—cardiovascular system—coronary artery disease	0.000164	0.0234	CbGeAlD
Drospirenone—Angiopathy—Fenofibrate—coronary artery disease	0.000164	0.0039	CcSEcCtD
Drospirenone—Acute coronary syndrome—Pravastatin—coronary artery disease	0.000164	0.0039	CcSEcCtD
Drospirenone—Erythema multiforme—Ezetimibe—coronary artery disease	0.000163	0.0039	CcSEcCtD
Drospirenone—Skin disorder—Gemfibrozil—coronary artery disease	0.000163	0.00389	CcSEcCtD
Drospirenone—Myocardial infarction—Pravastatin—coronary artery disease	0.000163	0.00388	CcSEcCtD
Drospirenone—Angiopathy—Clopidogrel—coronary artery disease	0.000161	0.00384	CcSEcCtD
Drospirenone—Nervous system disorder—Ticagrelor—coronary artery disease	0.000161	0.00384	CcSEcCtD
Drospirenone—Depression—Trandolapril—coronary artery disease	0.000161	0.00383	CcSEcCtD
Drospirenone—Depression—Enalapril—coronary artery disease	0.00016	0.00382	CcSEcCtD
Drospirenone—AR—blood—coronary artery disease	0.00016	0.0227	CbGeAlD
Drospirenone—Skin disorder—Ticagrelor—coronary artery disease	0.000159	0.0038	CcSEcCtD
Drospirenone—Cerebrovascular accident—Ramipril—coronary artery disease	0.000159	0.0038	CcSEcCtD
Drospirenone—Acute coronary syndrome—Trandolapril—coronary artery disease	0.000159	0.00379	CcSEcCtD
Drospirenone—Acute coronary syndrome—Enalapril—coronary artery disease	0.000158	0.00377	CcSEcCtD
Drospirenone—Mental disorder—Fenofibrate—coronary artery disease	0.000158	0.00377	CcSEcCtD
Drospirenone—Myocardial infarction—Trandolapril—coronary artery disease	0.000158	0.00377	CcSEcCtD
Drospirenone—Depression—Telmisartan—coronary artery disease	0.000158	0.00376	CcSEcCtD
Drospirenone—Myocardial infarction—Enalapril—coronary artery disease	0.000157	0.00375	CcSEcCtD
Drospirenone—Angiopathy—Ezetimibe—coronary artery disease	0.000157	0.00374	CcSEcCtD
Drospirenone—Haemoglobin—Valsartan—coronary artery disease	0.000156	0.00373	CcSEcCtD
Drospirenone—Acute coronary syndrome—Telmisartan—coronary artery disease	0.000156	0.00372	CcSEcCtD
Drospirenone—Erythema multiforme—Simvastatin—coronary artery disease	0.000156	0.00371	CcSEcCtD
Drospirenone—Spironolactone—NR3C2—coronary artery disease	0.000156	0.105	CrCbGaD
Drospirenone—Cerebrovascular accident—Timolol—coronary artery disease	0.000156	0.00371	CcSEcCtD
Drospirenone—Haemorrhage—Valsartan—coronary artery disease	0.000156	0.00371	CcSEcCtD
Drospirenone—Mental disorder—Clopidogrel—coronary artery disease	0.000155	0.0037	CcSEcCtD
Drospirenone—Myocardial infarction—Telmisartan—coronary artery disease	0.000155	0.0037	CcSEcCtD
Drospirenone—Angiopathy—Eplerenone—coronary artery disease	0.000154	0.00366	CcSEcCtD
Drospirenone—Haemoglobin—Niacin—coronary artery disease	0.000152	0.00363	CcSEcCtD
Drospirenone—Mental disorder—Ezetimibe—coronary artery disease	0.000151	0.00361	CcSEcCtD
Drospirenone—Haemorrhage—Niacin—coronary artery disease	0.000151	0.00361	CcSEcCtD
Drospirenone—Affect lability—Timolol—coronary artery disease	0.00015	0.00358	CcSEcCtD
Drospirenone—BCHE—cardiac atrium—coronary artery disease	0.000149	0.0212	CbGeAlD
Drospirenone—Mental disorder—Eplerenone—coronary artery disease	0.000148	0.00353	CcSEcCtD
Drospirenone—Acute coronary syndrome—Perindopril—coronary artery disease	0.000147	0.00351	CcSEcCtD
Drospirenone—Myocardial infarction—Perindopril—coronary artery disease	0.000147	0.00349	CcSEcCtD
Drospirenone—Hydrocortisone—CYP11B2—coronary artery disease	0.000146	0.0979	CrCbGaD
Drospirenone—Gastrointestinal disorder—Gemfibrozil—coronary artery disease	0.000145	0.00346	CcSEcCtD
Drospirenone—Nervous system disorder—Rosuvastatin—coronary artery disease	0.000145	0.00345	CcSEcCtD
Drospirenone—Mood swings—Timolol—coronary artery disease	0.000145	0.00344	CcSEcCtD
Drospirenone—Cerebrovascular accident—Lisinopril—coronary artery disease	0.000144	0.00344	CcSEcCtD
Drospirenone—Mental disorder—Simvastatin—coronary artery disease	0.000144	0.00344	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Ticagrelor—coronary artery disease	0.000142	0.00338	CcSEcCtD
Drospirenone—Angiopathy—Valsartan—coronary artery disease	0.000141	0.00337	CcSEcCtD
Drospirenone—Breast disorder—Ramipril—coronary artery disease	0.000141	0.00336	CcSEcCtD
Drospirenone—Erythema multiforme—Pravastatin—coronary artery disease	0.000141	0.00336	CcSEcCtD
Drospirenone—Nausea—Pitavastatin—coronary artery disease	0.000141	0.00336	CcSEcCtD
Drospirenone—Angiopathy—Olmesartan—coronary artery disease	0.000141	0.00335	CcSEcCtD
Drospirenone—Breast disorder—Timolol—coronary artery disease	0.000138	0.00329	CcSEcCtD
Drospirenone—Angiopathy—Niacin—coronary artery disease	0.000137	0.00327	CcSEcCtD
Drospirenone—Erythema multiforme—Trandolapril—coronary artery disease	0.000137	0.00326	CcSEcCtD
Drospirenone—Mental disorder—Valsartan—coronary artery disease	0.000136	0.00325	CcSEcCtD
Drospirenone—Erythema multiforme—Enalapril—coronary artery disease	0.000136	0.00325	CcSEcCtD
Drospirenone—Mental disorder—Olmesartan—coronary artery disease	0.000136	0.00324	CcSEcCtD
Drospirenone—Haemoglobin—Perindopril—coronary artery disease	0.000135	0.00322	CcSEcCtD
Drospirenone—Haemorrhage—Perindopril—coronary artery disease	0.000134	0.0032	CcSEcCtD
Drospirenone—PTGS2—heart—coronary artery disease	0.000134	0.0191	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Fenofibrate—coronary artery disease	0.000133	0.00317	CcSEcCtD
Drospirenone—Angiopathy—Trandolapril—coronary artery disease	0.000131	0.00313	CcSEcCtD
Drospirenone—Erythema multiforme—Captopril—coronary artery disease	0.000131	0.00312	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Clopidogrel—coronary artery disease	0.000131	0.00311	CcSEcCtD
Drospirenone—BCHE—blood—coronary artery disease	0.00013	0.0185	CbGeAlD
Drospirenone—Angiopathy—Telmisartan—coronary artery disease	0.000129	0.00307	CcSEcCtD
Drospirenone—Breast disorder—Lisinopril—coronary artery disease	0.000128	0.00305	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—coronary artery disease	0.000127	0.00303	CcSEcCtD
Drospirenone—Erythema multiforme—Perindopril—coronary artery disease	0.000127	0.00302	CcSEcCtD
Drospirenone—Mental disorder—Trandolapril—coronary artery disease	0.000127	0.00302	CcSEcCtD
Drospirenone—PTGS2—cardiovascular system—coronary artery disease	0.000127	0.018	CbGeAlD
Drospirenone—Nervous system disorder—Fenofibrate—coronary artery disease	0.000126	0.003	CcSEcCtD
Drospirenone—Mental disorder—Telmisartan—coronary artery disease	0.000125	0.00297	CcSEcCtD
Drospirenone—Skin disorder—Fenofibrate—coronary artery disease	0.000125	0.00297	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Eplerenone—coronary artery disease	0.000125	0.00297	CcSEcCtD
Drospirenone—Nervous system disorder—Clopidogrel—coronary artery disease	0.000124	0.00295	CcSEcCtD
Drospirenone—Erythema multiforme—Furosemide—coronary artery disease	0.000123	0.00294	CcSEcCtD
Drospirenone—Skin disorder—Clopidogrel—coronary artery disease	0.000122	0.00292	CcSEcCtD
Drospirenone—Angiopathy—Perindopril—coronary artery disease	0.000122	0.0029	CcSEcCtD
Drospirenone—Nervous system disorder—Ezetimibe—coronary artery disease	0.00012	0.00287	CcSEcCtD
Drospirenone—Skin disorder—Ezetimibe—coronary artery disease	0.000119	0.00284	CcSEcCtD
Drospirenone—Erythema multiforme—Losartan—coronary artery disease	0.000119	0.00284	CcSEcCtD
Drospirenone—Acute coronary syndrome—Ramipril—coronary artery disease	0.000119	0.00283	CcSEcCtD
Drospirenone—Angiopathy—Furosemide—coronary artery disease	0.000118	0.00282	CcSEcCtD
Drospirenone—Myocardial infarction—Ramipril—coronary artery disease	0.000118	0.00281	CcSEcCtD
Drospirenone—Nervous system disorder—Eplerenone—coronary artery disease	0.000118	0.00281	CcSEcCtD
Drospirenone—Mental disorder—Perindopril—coronary artery disease	0.000118	0.0028	CcSEcCtD
Drospirenone—Depression—Timolol—coronary artery disease	0.000117	0.00279	CcSEcCtD
Drospirenone—Nausea—Penbutolol—coronary artery disease	0.000117	0.00279	CcSEcCtD
Drospirenone—Skin disorder—Eplerenone—coronary artery disease	0.000117	0.00278	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—coronary artery disease	0.000115	0.00273	CcSEcCtD
Drospirenone—Angiopathy—Losartan—coronary artery disease	0.000114	0.00272	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—coronary artery disease	0.000114	0.00272	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Niacin—coronary artery disease	0.000111	0.00266	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.000111	0.00264	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000109	0.00259	CcSEcCtD
Drospirenone—Depression—Lisinopril—coronary artery disease	0.000109	0.00259	CcSEcCtD
Drospirenone—Nervous system disorder—Valsartan—coronary artery disease	0.000108	0.00259	CcSEcCtD
Drospirenone—Nervous system disorder—Olmesartan—coronary artery disease	0.000108	0.00257	CcSEcCtD
Drospirenone—Acute coronary syndrome—Lisinopril—coronary artery disease	0.000108	0.00256	CcSEcCtD
Drospirenone—Skin disorder—Valsartan—coronary artery disease	0.000107	0.00256	CcSEcCtD
Drospirenone—Skin disorder—Olmesartan—coronary artery disease	0.000107	0.00255	CcSEcCtD
Drospirenone—Myocardial infarction—Lisinopril—coronary artery disease	0.000107	0.00255	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	0.000107	0.00254	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.000106	0.00253	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	0.000105	0.00249	CcSEcCtD
Drospirenone—Skin disorder—Niacin—coronary artery disease	0.000104	0.00249	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000104	0.00247	CcSEcCtD
Drospirenone—Erythema multiforme—Ramipril—coronary artery disease	0.000102	0.00243	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000101	0.00241	CcSEcCtD
Drospirenone—Nervous system disorder—Trandolapril—coronary artery disease	0.000101	0.0024	CcSEcCtD
Drospirenone—PTGS2—blood—coronary artery disease	0.0001	0.0143	CbGeAlD
Drospirenone—Skin disorder—Trandolapril—coronary artery disease	9.99e-05	0.00238	CcSEcCtD
Drospirenone—Nausea—Gemfibrozil—coronary artery disease	9.98e-05	0.00238	CcSEcCtD
Drospirenone—Nervous system disorder—Telmisartan—coronary artery disease	9.91e-05	0.00236	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	9.88e-05	0.00235	CcSEcCtD
Drospirenone—Skin disorder—Telmisartan—coronary artery disease	9.81e-05	0.00234	CcSEcCtD
Drospirenone—Nausea—Ticagrelor—coronary artery disease	9.75e-05	0.00232	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	9.61e-05	0.00229	CcSEcCtD
Drospirenone—Angiopathy—Timolol—coronary artery disease	9.58e-05	0.00228	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Valsartan—coronary artery disease	9.55e-05	0.00228	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Olmesartan—coronary artery disease	9.5e-05	0.00226	CcSEcCtD
Drospirenone—Mental disorder—Ramipril—coronary artery disease	9.46e-05	0.00225	CcSEcCtD
Drospirenone—Nervous system disorder—Perindopril—coronary artery disease	9.35e-05	0.00223	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Niacin—coronary artery disease	9.29e-05	0.00221	CcSEcCtD
Drospirenone—Skin disorder—Perindopril—coronary artery disease	9.26e-05	0.00221	CcSEcCtD
Drospirenone—Erythema multiforme—Lisinopril—coronary artery disease	9.26e-05	0.00221	CcSEcCtD
Drospirenone—Mental disorder—Timolol—coronary artery disease	9.25e-05	0.0022	CcSEcCtD
Drospirenone—Nervous system disorder—Furosemide—coronary artery disease	9.09e-05	0.00217	CcSEcCtD
Drospirenone—Skin disorder—Furosemide—coronary artery disease	9.01e-05	0.00215	CcSEcCtD
Drospirenone—Angiopathy—Lisinopril—coronary artery disease	8.88e-05	0.00212	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Trandolapril—coronary artery disease	8.88e-05	0.00212	CcSEcCtD
Drospirenone—Nausea—Rosuvastatin—coronary artery disease	8.78e-05	0.00209	CcSEcCtD
Drospirenone—Nervous system disorder—Losartan—coronary artery disease	8.77e-05	0.00209	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Telmisartan—coronary artery disease	8.72e-05	0.00208	CcSEcCtD
Drospirenone—Mental disorder—Lisinopril—coronary artery disease	8.58e-05	0.00204	CcSEcCtD
Drospirenone—Nausea—Acetylsalicylic acid—coronary artery disease	8.53e-05	0.00203	CcSEcCtD
Drospirenone—Progesterone—NR3C2—coronary artery disease	8.44e-05	0.0566	CrCbGaD
Drospirenone—Gastrointestinal disorder—Perindopril—coronary artery disease	8.23e-05	0.00196	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Furosemide—coronary artery disease	8.01e-05	0.00191	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.95e-05	0.00189	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.77e-05	0.00185	CcSEcCtD
Drospirenone—Nausea—Fenofibrate—coronary artery disease	7.62e-05	0.00182	CcSEcCtD
Drospirenone—Nervous system disorder—Ramipril—coronary artery disease	7.52e-05	0.00179	CcSEcCtD
Drospirenone—Nausea—Clopidogrel—coronary artery disease	7.49e-05	0.00178	CcSEcCtD
Drospirenone—Skin disorder—Ramipril—coronary artery disease	7.45e-05	0.00178	CcSEcCtD
Drospirenone—Nausea—Lovastatin—coronary artery disease	7.44e-05	0.00177	CcSEcCtD
Drospirenone—Nervous system disorder—Timolol—coronary artery disease	7.35e-05	0.00175	CcSEcCtD
Drospirenone—Nausea—Ezetimibe—coronary artery disease	7.3e-05	0.00174	CcSEcCtD
Drospirenone—Skin disorder—Timolol—coronary artery disease	7.28e-05	0.00174	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	7.21e-05	0.00172	CcSEcCtD
Drospirenone—Nausea—Eplerenone—coronary artery disease	7.14e-05	0.0017	CcSEcCtD
Drospirenone—Nausea—Simvastatin—coronary artery disease	6.96e-05	0.00166	CcSEcCtD
Drospirenone—Skin disorder—Lisinopril—coronary artery disease	6.76e-05	0.00161	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Ramipril—coronary artery disease	6.62e-05	0.00158	CcSEcCtD
Drospirenone—Nausea—Valsartan—coronary artery disease	6.57e-05	0.00157	CcSEcCtD
Drospirenone—Nausea—Olmesartan—coronary artery disease	6.54e-05	0.00156	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Timolol—coronary artery disease	6.47e-05	0.00154	CcSEcCtD
Drospirenone—Nausea—Niacin—coronary artery disease	6.39e-05	0.00152	CcSEcCtD
Drospirenone—Nausea—Pravastatin—coronary artery disease	6.29e-05	0.0015	CcSEcCtD
Drospirenone—Nausea—Trandolapril—coronary artery disease	6.11e-05	0.00146	CcSEcCtD
Drospirenone—Nausea—Enalapril—coronary artery disease	6.08e-05	0.00145	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.01e-05	0.00143	CcSEcCtD
Drospirenone—Nausea—Telmisartan—coronary artery disease	6e-05	0.00143	CcSEcCtD
Drospirenone—Progesterone—SLC22A3—coronary artery disease	5.89e-05	0.0395	CrCbGaD
Drospirenone—Nausea—Captopril—coronary artery disease	5.84e-05	0.00139	CcSEcCtD
Drospirenone—Nausea—Perindopril—coronary artery disease	5.67e-05	0.00135	CcSEcCtD
Drospirenone—Testosterone—SLC22A3—coronary artery disease	5.57e-05	0.0374	CrCbGaD
Drospirenone—Nausea—Furosemide—coronary artery disease	5.51e-05	0.00131	CcSEcCtD
Drospirenone—Nausea—Losartan—coronary artery disease	5.31e-05	0.00127	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—ESR1—coronary artery disease	5.01e-05	0.0336	CrCbGaD
Drospirenone—Nausea—Ramipril—coronary artery disease	4.56e-05	0.00109	CcSEcCtD
Drospirenone—Nausea—Timolol—coronary artery disease	4.45e-05	0.00106	CcSEcCtD
Drospirenone—Nausea—Lisinopril—coronary artery disease	4.13e-05	0.000985	CcSEcCtD
Drospirenone—Norethindrone—CYP2C19—coronary artery disease	3.98e-05	0.0267	CrCbGaD
Drospirenone—Progesterone—ESR1—coronary artery disease	2.89e-05	0.0194	CrCbGaD
Drospirenone—Progesterone—CYP2C19—coronary artery disease	2.32e-05	0.0156	CrCbGaD
Drospirenone—Norethindrone—ALB—coronary artery disease	2.21e-05	0.0148	CrCbGaD
Drospirenone—Testosterone—CYP2C19—coronary artery disease	2.19e-05	0.0147	CrCbGaD
Drospirenone—Methyltestosterone—ALB—coronary artery disease	2.1e-05	0.0141	CrCbGaD
Drospirenone—Testosterone—ALB—coronary artery disease	1.22e-05	0.00817	CrCbGaD
Drospirenone—AR—Gene Expression—SIRT1—coronary artery disease	5.25e-06	0.000152	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOC3—coronary artery disease	5.23e-06	0.000151	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—LEP—coronary artery disease	5.22e-06	0.000151	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—LDLR—coronary artery disease	5.2e-06	0.00015	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	5.2e-06	0.00015	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP11B2—coronary artery disease	5.19e-06	0.00015	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TXNRD1—coronary artery disease	5.19e-06	0.00015	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ESR1—coronary artery disease	5.19e-06	0.00015	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—MAPK1—coronary artery disease	5.19e-06	0.00015	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.19e-06	0.00015	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ITGAV—coronary artery disease	5.17e-06	0.000149	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KNG1—coronary artery disease	5.16e-06	0.000149	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC9A1—coronary artery disease	5.13e-06	0.000148	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTT1—coronary artery disease	5.13e-06	0.000148	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGTR1—coronary artery disease	5.13e-06	0.000148	CbGpPWpGaD
Drospirenone—PTGS2—Disease—P4HB—coronary artery disease	5.12e-06	0.000148	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC22A3—coronary artery disease	5.11e-06	0.000148	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GCLC—coronary artery disease	5.07e-06	0.000146	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CETP—coronary artery disease	5.07e-06	0.000146	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ARNTL—coronary artery disease	5.04e-06	0.000145	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HADH—coronary artery disease	5.04e-06	0.000145	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPP3R1—coronary artery disease	5.02e-06	0.000145	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SDC1—coronary artery disease	5.02e-06	0.000145	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL10—coronary artery disease	5.01e-06	0.000145	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PLG—coronary artery disease	5e-06	0.000144	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	4.96e-06	0.000143	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	4.93e-06	0.000142	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—F2—coronary artery disease	4.92e-06	0.000142	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRB2—coronary artery disease	4.86e-06	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NPPA—coronary artery disease	4.85e-06	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CYBB—coronary artery disease	4.85e-06	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	4.84e-06	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	4.84e-06	0.00014	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCE—coronary artery disease	4.8e-06	0.000139	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SOCS1—coronary artery disease	4.79e-06	0.000138	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—S100B—coronary artery disease	4.78e-06	0.000138	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOA2—coronary artery disease	4.78e-06	0.000138	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLA2G2A—coronary artery disease	4.78e-06	0.000138	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GPX2—coronary artery disease	4.78e-06	0.000138	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PSMA6—coronary artery disease	4.74e-06	0.000137	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PSMB5—coronary artery disease	4.74e-06	0.000137	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARG—coronary artery disease	4.74e-06	0.000137	CbGpPWpGaD
Drospirenone—PTGS2—Disease—VCAN—coronary artery disease	4.73e-06	0.000137	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAP2K3—coronary artery disease	4.73e-06	0.000137	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.73e-06	0.000137	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SOCS3—coronary artery disease	4.73e-06	0.000137	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GPX4—coronary artery disease	4.72e-06	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SULT1A1—coronary artery disease	4.72e-06	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCG5—coronary artery disease	4.72e-06	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HK1—coronary artery disease	4.72e-06	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	4.71e-06	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ALDOA—coronary artery disease	4.7e-06	0.000136	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KITLG—coronary artery disease	4.68e-06	0.000135	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFBR2—coronary artery disease	4.68e-06	0.000135	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HADHA—coronary artery disease	4.66e-06	0.000135	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPP2CA—coronary artery disease	4.64e-06	0.000134	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CTGF—coronary artery disease	4.63e-06	0.000134	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTA1—coronary artery disease	4.61e-06	0.000133	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	4.61e-06	0.000133	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CST3—coronary artery disease	4.59e-06	0.000133	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GOT2—coronary artery disease	4.59e-06	0.000132	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMGCR—coronary artery disease	4.59e-06	0.000132	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP3—coronary artery disease	4.57e-06	0.000132	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT5A—coronary artery disease	4.57e-06	0.000132	CbGpPWpGaD
Drospirenone—PTGS2—Disease—DCN—coronary artery disease	4.56e-06	0.000132	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LPA—coronary artery disease	4.56e-06	0.000132	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PRKCD—coronary artery disease	4.55e-06	0.000131	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—POMC—coronary artery disease	4.48e-06	0.000129	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOB—coronary artery disease	4.42e-06	0.000127	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLCB3—coronary artery disease	4.41e-06	0.000127	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—coronary artery disease	4.39e-06	0.000127	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOA5—coronary artery disease	4.37e-06	0.000126	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EDN1—coronary artery disease	4.35e-06	0.000125	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—IGF1—coronary artery disease	4.31e-06	0.000125	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL5—coronary artery disease	4.31e-06	0.000124	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOC3—coronary artery disease	4.3e-06	0.000124	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—P4HB—coronary artery disease	4.28e-06	0.000124	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LDLR—coronary artery disease	4.27e-06	0.000123	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SERPINE1—coronary artery disease	4.27e-06	0.000123	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF1—coronary artery disease	4.25e-06	0.000123	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CSF2—coronary artery disease	4.25e-06	0.000123	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.24e-06	0.000122	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PLCB1—coronary artery disease	4.22e-06	0.000122	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC9A1—coronary artery disease	4.22e-06	0.000122	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LPL—coronary artery disease	4.22e-06	0.000122	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLA2G1B—coronary artery disease	4.21e-06	0.000121	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	4.2e-06	0.000121	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RPS6KB1—coronary artery disease	4.18e-06	0.000121	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MEF2C—coronary artery disease	4.18e-06	0.000121	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—coronary artery disease	4.17e-06	0.00012	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.16e-06	0.00012	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.14e-06	0.000119	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SDC1—coronary artery disease	4.12e-06	0.000119	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.11e-06	0.000119	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCA1—coronary artery disease	4.09e-06	0.000118	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ITGB3—coronary artery disease	4.07e-06	0.000118	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MAPK14—coronary artery disease	4.03e-06	0.000116	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—VCAN—coronary artery disease	3.96e-06	0.000114	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GOT1—coronary artery disease	3.96e-06	0.000114	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GGT1—coronary artery disease	3.96e-06	0.000114	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PPP2CA—coronary artery disease	3.96e-06	0.000114	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ESR1—coronary artery disease	3.95e-06	0.000114	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDOA—coronary artery disease	3.93e-06	0.000114	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PSMB5—coronary artery disease	3.9e-06	0.000112	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PSMA6—coronary artery disease	3.9e-06	0.000112	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCD—coronary artery disease	3.89e-06	0.000112	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—DCN—coronary artery disease	3.82e-06	0.00011	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR2A—coronary artery disease	3.8e-06	0.00011	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—C3—coronary artery disease	3.8e-06	0.00011	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GOT2—coronary artery disease	3.77e-06	0.000109	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CYBA—coronary artery disease	3.76e-06	0.000108	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALR—coronary artery disease	3.74e-06	0.000108	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDH2—coronary artery disease	3.72e-06	0.000107	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.62e-06	0.000105	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIF1A—coronary artery disease	3.62e-06	0.000105	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2C19—coronary artery disease	3.62e-06	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3C2A—coronary artery disease	3.62e-06	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HBA1—coronary artery disease	3.62e-06	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LIPC—coronary artery disease	3.62e-06	0.000104	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARG—coronary artery disease	3.61e-06	0.000104	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGT—coronary artery disease	3.61e-06	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOC3—coronary artery disease	3.6e-06	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LDLR—coronary artery disease	3.58e-06	0.000103	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.57e-06	0.000103	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTP1—coronary artery disease	3.56e-06	0.000103	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOE—coronary artery disease	3.54e-06	0.000102	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LEP—coronary artery disease	3.54e-06	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC9A1—coronary artery disease	3.53e-06	0.000102	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTT1—coronary artery disease	3.53e-06	0.000102	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARGC1A—coronary artery disease	3.53e-06	0.000102	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMOX1—coronary artery disease	3.51e-06	0.000101	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOA1—coronary artery disease	3.49e-06	0.000101	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GCLC—coronary artery disease	3.49e-06	0.000101	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CETP—coronary artery disease	3.49e-06	0.000101	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JUNB—coronary artery disease	3.48e-06	0.0001	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HSPA1A—coronary artery disease	3.48e-06	0.0001	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—coronary artery disease	3.47e-06	0.0001	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KDR—coronary artery disease	3.46e-06	0.0001	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CAT—coronary artery disease	3.46e-06	9.99e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SDC1—coronary artery disease	3.45e-06	9.97e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK14—coronary artery disease	3.44e-06	9.93e-05	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.43e-06	9.9e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ESR1—coronary artery disease	3.38e-06	9.74e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOB—coronary artery disease	3.36e-06	9.7e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—F2—coronary artery disease	3.33e-06	9.62e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FN1—coronary artery disease	3.33e-06	9.62e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6ST—coronary artery disease	3.32e-06	9.58e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NFKBIA—coronary artery disease	3.29e-06	9.51e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTM1—coronary artery disease	3.27e-06	9.44e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PSMA6—coronary artery disease	3.26e-06	9.42e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PSMB5—coronary artery disease	3.26e-06	9.42e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.26e-06	9.4e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GOT1—coronary artery disease	3.26e-06	9.4e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SERPINE1—coronary artery disease	3.25e-06	9.38e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—LPL—coronary artery disease	3.21e-06	9.26e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KIT—coronary artery disease	3.19e-06	9.21e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CTGF—coronary artery disease	3.19e-06	9.2e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GOT2—coronary artery disease	3.16e-06	9.12e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMGCR—coronary artery disease	3.16e-06	9.12e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GPX1—coronary artery disease	3.13e-06	9.04e-05	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—coronary artery disease	3.07e-06	8.87e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GSK3B—coronary artery disease	3.06e-06	8.84e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CD36—coronary artery disease	3.05e-06	8.8e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CREB1—coronary artery disease	3.04e-06	8.76e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—POMC—coronary artery disease	3.04e-06	8.76e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPP2CA—coronary artery disease	3.01e-06	8.69e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCE—coronary artery disease	3e-06	8.67e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—coronary artery disease	2.97e-06	8.58e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6R—coronary artery disease	2.96e-06	8.55e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KITLG—coronary artery disease	2.92e-06	8.44e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFBR2—coronary artery disease	2.92e-06	8.44e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1—coronary artery disease	2.92e-06	8.43e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLCB1—coronary artery disease	2.9e-06	8.38e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—coronary artery disease	2.89e-06	8.34e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STAT5A—coronary artery disease	2.86e-06	8.25e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCA1—coronary artery disease	2.82e-06	8.13e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SERPINE1—coronary artery disease	2.77e-06	8.01e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOB—coronary artery disease	2.76e-06	7.97e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AGT—coronary artery disease	2.75e-06	7.93e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GGT1—coronary artery disease	2.73e-06	7.87e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GOT1—coronary artery disease	2.73e-06	7.87e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOE—coronary artery disease	2.69e-06	7.77e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF2—coronary artery disease	2.69e-06	7.75e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOA1—coronary artery disease	2.66e-06	7.68e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF1—coronary artery disease	2.66e-06	7.67e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOS3—coronary artery disease	2.65e-06	7.64e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LPL—coronary artery disease	2.64e-06	7.61e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JAK2—coronary artery disease	2.57e-06	7.43e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.55e-06	7.35e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPP2CA—coronary artery disease	2.48e-06	7.14e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTP1—coronary artery disease	2.45e-06	7.07e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PRKCD—coronary artery disease	2.43e-06	7.02e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARGC1A—coronary artery disease	2.43e-06	7e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMOX1—coronary artery disease	2.42e-06	6.97e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CAT—coronary artery disease	2.38e-06	6.88e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—coronary artery disease	2.38e-06	6.86e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—coronary artery disease	2.35e-06	6.78e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARG—coronary artery disease	2.34e-06	6.76e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOB—coronary artery disease	2.31e-06	6.68e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—POMC—coronary artery disease	2.31e-06	6.67e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIF1A—coronary artery disease	2.27e-06	6.54e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTM1—coronary artery disease	2.25e-06	6.5e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—coronary artery disease	2.25e-06	6.49e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOE—coronary artery disease	2.21e-06	6.38e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LPL—coronary artery disease	2.21e-06	6.38e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—coronary artery disease	2.19e-06	6.32e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOA1—coronary artery disease	2.19e-06	6.31e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GPX1—coronary artery disease	2.16e-06	6.22e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—coronary artery disease	2.12e-06	6.13e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—coronary artery disease	2.11e-06	6.08e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CD36—coronary artery disease	2.1e-06	6.06e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6ST—coronary artery disease	2.08e-06	5.99e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPP2CA—coronary artery disease	2.07e-06	5.98e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—coronary artery disease	2.06e-06	5.95e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NOS3—coronary artery disease	2.02e-06	5.82e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KIT—coronary artery disease	2e-06	5.76e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—coronary artery disease	1.99e-06	5.74e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GSK3B—coronary artery disease	1.92e-06	5.53e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—coronary artery disease	1.91e-06	5.51e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CREB1—coronary artery disease	1.9e-06	5.48e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AGT—coronary artery disease	1.89e-06	5.46e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—coronary artery disease	1.87e-06	5.4e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6R—coronary artery disease	1.85e-06	5.35e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOE—coronary artery disease	1.85e-06	5.35e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—coronary artery disease	1.84e-06	5.32e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOA1—coronary artery disease	1.83e-06	5.28e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.75e-06	5.06e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—coronary artery disease	1.75e-06	5.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SERPINE1—coronary artery disease	1.74e-06	5.01e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK1—coronary artery disease	1.72e-06	4.96e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF2—coronary artery disease	1.68e-06	4.85e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS3—coronary artery disease	1.66e-06	4.78e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARG—coronary artery disease	1.61e-06	4.66e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JAK2—coronary artery disease	1.61e-06	4.65e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—POMC—coronary artery disease	1.59e-06	4.59e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—coronary artery disease	1.49e-06	4.3e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—coronary artery disease	1.45e-06	4.19e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—coronary artery disease	1.43e-06	4.12e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NOS3—coronary artery disease	1.39e-06	4e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—coronary artery disease	1.32e-06	3.81e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—coronary artery disease	1.22e-06	3.51e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—coronary artery disease	1.13e-06	3.27e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—coronary artery disease	1.1e-06	3.16e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MAPK1—coronary artery disease	1.07e-06	3.1e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—coronary artery disease	9.32e-07	2.69e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—coronary artery disease	9.27e-07	2.67e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—coronary artery disease	8.25e-07	2.38e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—coronary artery disease	7.81e-07	2.25e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—coronary artery disease	7.62e-07	2.2e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—coronary artery disease	6.38e-07	1.84e-05	CbGpPWpGaD
